Seven Eight Capital, LP Moderna, Inc. Transaction History

Seven Eight Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $459,776 - $1 Million	-2,072 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $851,040 - $1.54 Million	-6,551 Reduced 75.97%	2,072 $487,000
Q4 2020 Feb 09, 2021	SELL	$65.74 - $169.86 $65,740 - $169,860	-1,000 Reduced 10.39%	8,623 $901,000
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $244,530 - $426,825	4,500 Added 87.84%	9,623 $681,000
Q2 2020 Aug 06, 2020	BUY	$29.67 - $80.0 $151,999 - $409,840	5,123 New	5,123 $329,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.